In addition to the Smad pathway, the AKT and MAPK pathways can directly contribute to bleomycin (BLM)-induced lung fibrosis by regulating fibroblast viability, differentiation, and migration13,14. This evidence concerns the gene AKT1 and pulmonary fibrosis.